跳至主要内容
临床试验/NCT06831565
NCT06831565招募中不适用

Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy: A Randomized Controlled Trial

Institute of Liver and Biliary Sciences, India2 个研究点 分布在 1 个国家目标入组 790 人开始时间: 2025年3月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
790
试验地点
2
主要终点
Proportion of patients with reduction in the amount of total components transfused in high cut off ROTEM compared to low cut off ROTEM in cirrhosis and ACLF patients.

研究概览

简要总结

Coagulation system in cirrhotics patients is a fragile state , which is rebalanced hemostasis. Standard tests (INR/aPTT) stop measuring at first stage of coagulation ,when the clot first form. VETs measure the whole process such as ROTEM, TEG and comparing these two tests to assess for transfusion of blood products for invasive procedures. . ROTEM provides information both on anti coagulant and procoagulant status where as conventional tests provide only anti coagulant status Invasive procedures can be low risk or high risk or Non surgical vs surgical, Procedure related bleed occurs in 7% of patients with cirrhosis and associated with higher 28 day mortality. MELD, CTP ,AKI , SEPSIS increase the risk of procedure related bleed. Hence for invasive procedures investigator is using relaxing threshold for blood product transfusion in cirrhosis, ACLF patients. As use of ROTEM when compared to conventional tests reduces the need for blood transfusion. Investigator want to proceed with further relaxation of cutoff values of Coagulation parameters and use High cutoff vs low cut off for blood transfusion need.

详细描述

Aim and Objective - To evaluate the efficacy and safety of relaxed threshold (compared to threshold) for blood product transfusion for invasive procedures in cirrhosis and ACLF patients.

Hypothesis - Relaxing the threshold ( as compared to conventional threshold ) for blood product transfusion will decrease the need for blood products without increase the bleeding complications for invasive procedures in cirrhosis and acute on chronic liver failure patients( ACLF)

Sample size with justification:

Assuming the prevalence rate is 50% (TUSHAR THESIS -yet to be published), that is need of transfusion of blood produtcs in standard cutoff and relaxed cutoff , as according to this study the need in relaxed cut off has been reduced,investigator assumed the need in High cut off group is reduced to 40%, with alpha-5%, power-80%, investigator need to enroll 417 in each group with defaulter of 10% , it decided to have cases that is 934 total Monitoring and assessment: All patients would undergo vital and baseline parameter screening before randomization. Based on randomization investigator will assess the need for transfusion , and complications post procedure , post transfusion if any for a duration of 1month.

Intervention: Patient after screening for all exclusion criteria will be randomized to procedure after or before transfusion of blood products and will be assessed the safety of procedure related bleed and need of intervention post procedure if any

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cirrhosis and ACLF ( as per definition)
  • Planned to undergo invasive procedures
  • Severe Coagulopathy- INR>2.0 or Platelets <30k or Fibrinogen<100mg/dl .

排除标准

  • Ongoing bleeding
  • Bleeding in past 48 hours before procedure
  • Antiplatelet or anticoagulant therapy ( stopped < 7 days before)

研究组 & 干预措施

Low Cut Off

Active Comparator

EXTEM CT>80sec, CL130<50% FIBTEM- Mcf>8

干预措施: ROTEM (Diagnostic Test)

High Cut Off

Experimental

EXTEM CT>100sec, CL130<40% FIBTEM- Mcf<6

干预措施: ROTEM (Diagnostic Test)

On demand

No Intervention

No pre procedure blood products transfusions will be given. Transfusions will be given after the procedure if any bleeding complications occur

结局指标

主要结局

Proportion of patients with reduction in the amount of total components transfused in high cut off ROTEM compared to low cut off ROTEM in cirrhosis and ACLF patients.

时间窗: Day 28

High Cutoff defined as need of low blood transfusion products (CT-\>100sec,MCF\<25,CLI30\<40%,MCF -FIB\<6mm) and Low Cut off defined as (CT -\>80sec, MCF\<35, CLI30\<50%,MCF-FIB\<6mm)

次要结局

  • Evaluate the incidence of bleeding events post procedure in Low cutoff.(Day 28)
  • Mortality related with procedural bleeding in both groups.(Day 28)
  • Assess the impact of ROTEM on transfusion requirements.(Day 28)
  • Proportion of the patient requiring procedural based treatment that is number of blood transfusions, angioembolization after post procedural bleed.(Day 28)
  • To compare the rate of transfusion reactions in relaxed ROTEM vs standard ROTEM in cirrhosis and ACLF.(Day 28)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验